Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of an NK1 Antagonist in Decreasing Symptoms of Post-Traumatic Stress Disorder
This study has been completed.
Study NCT00211861   Information provided by National Institute of Mental Health (NIMH)
First Received: September 15, 2005   Last Updated: April 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stress Disorders
Post-Traumatic Stress Disorder
Additional conditions recognized in this trial
Disease
Stress
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Pathologic Processes
Interventions listed in this trial
NK1 antagonist GR205171
Placebo
Additional drug interventions recognized in this trial
GR 205171
More general drug interventions related to this trial
Antiemetics
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services